Look Ahead...

Regulatory Questions Remain As FDA’s CBD Report Deadline Looms

By Beth Wang / January 9, 2020 at 12:22 PM
FDA must soon update Congress on its plan for regulating cannabidiol (CBD) products, but there are myriad issues the agency still needs to grapple with as that deadline looms. The agency has consistently said it needs more data on CBD and its health effects, and it has yet to clarify whether it will allow CBD in food and dietary supplements. Once it makes a decision on what products can contain CBD, experts wonder how FDA will exercise its enforcement authority...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.